Overall evaluation of effectiveness of type II thyroplasty for adductor spasmodic dysphonia

Laryngoscope

Volumn 117, Issue 12, 2007, Pages 2255-2259

  Sanuki, Tetsuji ^a,c   Isshiki, Nobuhiko ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Kyoto Voice Surgery Center   (Japan)

^c NONE   (Japan)

Author keywords

Adductor spasmodic dysphonia; Assessment; Questionnaire; Surgery; Thyroplasty; Voice

Indexed keywords

TITANIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DYSPHONIA; FEMALE; FOLLOW UP; HUMAN; LARYNGOSCOPY; MALE; MEDICAL RECORD; PHONATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; SCORING SYSTEM; SPASMODIC DYSPHONIA; STRANGULATION; SURGICAL TECHNIQUE; TREMOR; TYPE II THYROPLASTY; VOICE;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHONATION; PROSTHESIS IMPLANTATION; RECONSTRUCTIVE SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; THYROID CARTILAGE; TIME FACTORS; TITANIUM; TREATMENT OUTCOME; VOICE DISORDERS;

EID: 40349091574     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e31814684fa     Document Type: Article

References (22)

1. Aronson AE, Brown JR, Litin EM, Pearson JS. Spastic dysphonia. Part I. Voice, neurologic, and psychiatric aspects. J Speech Hear Disord 1968;33:203-218.
2. Izdebski K, Dedo HH, Boles L. Spastic dysphonia: a patient profile of 200 cases. Am J Otolaryngol 1984;5:7-14.
3. Zwirner P, Dressler D, Kruse E. Spasmodic laryngeal dyspnea: a rare manifestation of laryngeal dystonia. Eur Arch Otorhinolaryngol 1997;254:242-245.
4. Dedo HH. Recurrent laryngeal nerve section for spastic dysphonia. Ann Otol Rhinol Laryngol 1976;85:451-459.
5. Aronson AE, De Santo LW. Adductor spastic dysphonia: three years after recurrent laryngeal nerve resection. Laryngoscope 1983;93:1-8.
6. Blitzer A, Brin MF, Fahn S, Lange D, Lovelace RE. Botulinum toxin (BOTOX) for the treatment of "spastic dysphonia" as part of a trial of toxin injections for the treatment of other cranial dystonias. Laryngoscope 1986;96:1300-1301.
7. Friedman M, Toriumi DM, Grybauskas VT, Applebaum EL. Implantation of a recurrent laryngeal nerve stimulator for the treatment of spastic dysphonia. Ann Otol Rhinol Laryngol 1989;98:130-134.
8. Netterville JL, Stone RE, Rainey C, Zealear DL, Ossoff RH. Recurrent laryngeal nerve avulsion for treatment of spastic dysphonia. Ann Otol Rhinol Laryngol 1991;100:10-14.
9. Roy N, Ford CN, Bless DM. Muscle tension dysphonia and spasmodic dysphonia: the role of manual laryngeal tension reduction in diagnosis and management. Ann Otol Rhinol Laryngol 1996;105:851-856.
10. Berke GS, Blackwell KE, Gerratt BR, Verneil A, Jackson KS, Sercarz JA. Selective laryngeal adductor denervation-reinnervation: a new surgical treatment for adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 1999;108:227-231.
11. Isshiki N, Tsuji DH, Yamamoto Y, Iizuka Y. Midline lateralization thyroplasty for adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 2000;109:187-193.
12. Tsunoda K, Amagai N, Kondou K, Baer T, Kaga K, Niimi S. Autologous replacement of the vocal fold: a new surgical approach for adduction-type spasmodic dysphonia. J Laryngol Otol 2005;119:222-225.
13. Tsuji DH, Chrispim FS, Imamura R, Sennes LU, Hachiya A. Impact in vocal quality in partial myectomy and neurectomy endoscopic of thyroarytenoid muscle in patients with adductor spasmodic dysphonia. Rev Bras Otorrinolaringol (Engl Ed) 2006;72:261-266.
14. Koufman JA, Rees CJ, Halum SL, Blalock D. Treatment of adductor-type spasmodic dysphonia by surgical myectomy: a preliminary report. Ann Otol Rhinol Laryngol 2006;115:97-102.
15. Isshiki N, Haji T, Yamamoto Y, Mahieu HF. Thyroplasty for adductor spasmodic dysphonia: further experiences. Laryngoscope 2001;111:615-621.
16. Isshiki N, Yamamoto I, Fukagai S. Type 2 thyroplasty for spasmodic dysphonia: fixation using a titanium bridge. Acta Otolaryngol 2004;124:309-312.
17. Sapir S. Psychogenic spasmodic dysphonia: a case study with expert opinions. J Voice 1995;9:270-281.
18. Davis PJ, Boone DR, Carroll RL, Darveniza P, Harrison GA. Adductor spastic dysphonia: heterogeneity of physiologic and phonatory characteristics. Ann Otol Rhinol Laryngol 1988;97:179-185.
19. Pool KD, Freeman FJ, Finitzo T, et al. Heterogeneity in spasmodic dysphonia. Neurologic and voice findings. Arch Neurol 1991;48:305-309.
20. Morrison MD, Rammage LA. Muscle misuse voice disorders: description and classification. Acta Otolaryngol 1993;113:428-434.
21. Kobayashi T, Niimi S, Kumada M, Kosaki H, Hirose H. Botulinum toxin treatment for spasmodic dysphonia. Acta Otolaryngol Suppl 1993;504:155-157.
22. Langeveld TP, van Rossum M, Houtman EH, Zwinderman AH, Briaire JJ, Baatenburg de Jong RJ. Evaluation of voice quality in adductor spasmodic dysphonia before and after botulinum toxin treatment. Ann Otol Rhinol Laryngol 2001;110:627-634.